BONESUPPORT delivered a strong Q3 report, beating both our estimates and consensus on sales and EBIT. Importantly, US CERAMENT G growth accelerated sharply following the somewhat softer Q2, while profitability reached new levels. With improved CMS reimbursement and the SOLARIO publication now in place, we believe BONESUPPORT enters 2027 in a very strong position. We suspect that yesterday’s strong share price reaction was partly driven by short sellers covering their positions.
LÄS MER
